About First Hospital of Lanzhou University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
BeiGene
3
Lifetech Scientific (Shenzhen) Co., Ltd.
2
Betta Pharmaceuticals Co., Ltd.
1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
1
Shanghai Junshi Bioscience Co., Ltd.
1
Shenyang Northern Hospital
1
Clinical Trials at First Hospital of Lanzhou University
During the past decade, First Hospital of Lanzhou University conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes
2008-12-01
2011-11-01
Completed
2,998
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
2014-03-01
2017-09-01
Unknown status
192
Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System
2018-09-30
2025-03-31
Active, not recruiting
156
Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY（PATENCY）
2019-02-01
2025-12-01
Enrolling by invitation
150
Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
2019-07-22
2023-10-01
Active, not recruiting
457
Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC
2020-10-15
2024-12-31
Active, not recruiting
326
Tislelizumab in Combination With Sitravatinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2021-07-27
2024-06-30
Recruiting
420
Ociperlimab With Tislelizumab and Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
2021-11-16
2024-11-01
Recruiting
270
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "First Hospital of Lanzhou University" #1 sponsor was "BeiGene" with 3 trials, followed by "Lifetech Scientific (Shenzhen) Co., Ltd." with 2 trials
sponsored, "Betta Pharmaceuticals Co., Ltd." with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Shanghai Junshi Bioscience Co., Ltd."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at First Hospital of Lanzhou University
According to Clinical.Site data, the most researched conditions in "First Hospital of Lanzhou University" are
"Abdominal Aortic Aneurysm" (1 trials), "Adenocarcinoma" (1 trials), "Advanced Hepatocellular Carcinoma (HCC)" (1 trials), "Chronic Kidney Disease" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "First Hospital of Lanzhou University" in a lesser frequency.
Clinical Trials Intervention Types at First Hospital of Lanzhou University
Most popular intervention types in "First Hospital of Lanzhou University" are "Drug" (7 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tislelizumab" (2 trials), "AK105 injection" (1 trials), "Abdominal Aortic Aneurysm Stent Graft System" (1 trials), "Anlotinib hydrochloride capsule" (1 trials) and "Artery Stent Graft System" (1 trials). Other intervention names were less common.
Clinical Trials Genders at First Hospital of Lanzhou University
The vast majority of trials in "First Hospital of Lanzhou University" are
9 trials for "All" genders.
Clinical Trials Status at First Hospital of Lanzhou University
Currently, there are NaN active trials in "First Hospital of Lanzhou University".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in First Hospital of Lanzhou University,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in First Hospital of Lanzhou University, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".